Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Covid-19 vaccination in patients with multiple myeloma: Focus on immune response.

American journal of hematology - 1 Aug 2021

Ludwig Heinz, San-Miguel Jesús, Munshi Nikhil, Sonneveld Pieter, Mateos María-Victoria, Moreau Philippe, Terpos Evangelos

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Antibody Specificity
Share to Antigenic Variation
Share to COVID-19 Vaccines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunity, Cellular

Share to Immunocompromised Host

Share to Immunogenicity, Vaccine

Share to Multiple Myeloma

Source

Open in PubMed Open full text

Identifiers

PMID: 34057243
DOI: 10.1002/ajh.26263
PMCID: PMC8212086

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Covid-19 vaccination in patients with multiple myeloma: Focus on immune response.PMID 34057243Read ↗

Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapySemantic proximity Read ↗

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myelomaSemantic proximity Read ↗

Activity of mRNA COVID-19 vaccines in patients with lymphoid malignanciesSemantic proximity Read ↗

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response in multiple myeloma patientsSemantic proximity Read ↗

Design of a novel NanoCAR construct that compares well with a conventional ScFv-based CAR targeting BCMA on multiple myelomaSemantic proximity Read ↗

Immunoinformatics Approach to Design a Multi-Epitope Vaccine Targeting GPRC5D in Multiple MyelomaSemantic proximity Read ↗

Loss of Anti-Spike Antibodies Following mRNA Vaccination for COVID-19 Among Patients with Multiple MyelomaSemantic proximity Read ↗

SARS-CoV-2 Vaccines in Patients With Multiple MyelomaSemantic proximity Read ↗

Perspectives on Drug Development in Multiple Myeloma-Looking Forward to 2025.Semantic proximity Read ↗

MicroRNAs immune response profile to COVID-19 vaccine boost in cancer patients under active treatmentSemantic proximity Read ↗

Long-term effects of idiotype vaccination on the specific T-cell response in peripheral blood and bone marrow of multiple myeloma patients.Semantic proximity Read ↗

Cellular Mechanisms Associated with Sub-Optimal Immune Responses to SARS-CoV-2 Bivalent Booster Vaccination in Patients with Multiple MyelomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.